- Home
- CLRB vs BEEM Comparison
CLRB vs BEEM Comparison
Compare CLRB & BEEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLRB | BEEM |
|---|---|---|
| Founded | 2002 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5M | 28.6M |
| IPO Year | 2008 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CLRB | BEEM |
|---|---|---|
| Price | $2.51 | $1.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $10.00 | $3.50 |
| AVG Volume (30 Days) | 26.0K | ★ 1.4M |
| Earning Date | 05-08-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 40.77 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $28,236,000.00 |
| Revenue This Year | N/A | $40.48 |
| Revenue Next Year | N/A | $32.17 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.20 | $0.97 |
| 52 Week High | $6.52 | $4.04 |
Technical Indicators
Market Signals| Indicator | CLRB | BEEM |
|---|---|---|
| Relative Strength Index (RSI) | 45.21 | 54.63 |
| Support Level | $2.44 | $1.38 |
| Resistance Level | $2.70 | $1.42 |
| Average True Range (ATR) | 0.10 | 0.14 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 24.00 | 47.01 |
Price Performance
Historical ComparisonAbout CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About BEEM Beam Global
Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.